GAMCO Investors’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

GAMCO Investors’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,540	Closed	-$3.97M	–	879
2023 Q4	$3.97M	Buy	+12,540	New	+$2.44M	0.04%	374

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

GAMCO Investors's KRTX Position: Q1 2024 in Review

GAMCO Investors sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 12,540 shares — an estimated $3.97M sold.

GAMCO Investors first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $3.97M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

GAMCO Investors reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
GAMCO Investors sold 12,540 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $3.97M.
GAMCO Investors first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
GAMCO Investors's Karuna Therapeutics, Inc. Common Stock position peaked at $3.97M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on GAMCO Investors's 13F filing for Q1 2024, filed 14 May 2024.